Stockreport

Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering

Seneca Biopharma, Inc.  (SNCA) 
PDF GERMANTOWN, Md., May 27, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various di [Read more]